Southwest Airlines (LUV)
$35.72 0.43 (1.22%)
6:00 EDT LUV Stock Quote Delayed 30 Minutes
Previous Close $35.29
Market Cap 20.71B
PE Ratio 5.92
Volume (Avg. Vol.) 1,553
Day's Range 35.29 - 35.29
52-Week Range 22.47 - 58.83
Dividend & Yield 0.57 (1.60%)
LUV Stock Predictions, Articles, and Southwest Airlines News
- From InvestorPlace
- From the Web
Powered by rebounding air travel demand, LUV stock is set to shake off Covid-19 risks and rebound back above $40 soon.
Powered by rebounding air travel demand and normalizing consumer behavior, airline stocks are positioned to once again fly high.
By Thomas Niel
But, at lower prices ($20 to $25 per share), LUV stock is a worthwhile bet on an air travel comeback.
Southwest Airlines stock has been through the wringer, but its balance sheet trumps its peers. What should we make of LUV stock now?
Long-term, Alibaba could be one of the best stocks to own over the next half-decade.
By Ian Cooper
It's time to sell United Airlines on fears of a "second wave" of the coronavirus. Until the fear dissipates, avoid UAL stock.
Airline stocks are still down in the dumps, compared to where they were as recently as February. But the situation is evolving rapidly.
Southwest took $3.2 billion from the government to assure its survival, and hopes to have its full route system running by December
By Thomas Niel
With investors betting on a V-shaped airline recovery, LUV stock has gotten ahead of itself. But, with strong fundamentals, consider buying at lower prices.
Southwest Airlines is bouncing back and layoffs are helping, but increased bookings would be better for LUV stock.
What doesn't kill a stock makes it stronger. Southwest Airlines just survived the mother of all survival tests and it's on its way back.
The coronavirus pandemic has made them cheap, but these stocks to sell are in trouble and have no place in your portfolio.
Southwest Airlines is a discount leader on a discount. But broader health and economic concerns are likely to keep LUV stock deflated for longer than investors think.
With evidence that travelers are gradually warming to the idea of flying, this may be the time to consider a speculative bet on LUV stock.
Other airlines are starting to go bankrupt. As their footprints shrink, Southwest will have the opportunity to seize great routes and build its market share.
By Ian Cooper
While I wouldn’t back up the truck on airlines now, LUV stock is a top blood-in-the-streets opportunity. It could reach $57 again soon.
Wednesday's big stock charts feature airlines that could face more turbulence this year
Vapotherm (NYSE:VAPO) -26% on Q2 earnings.New Relic (NYSE:NEWR) -19% on Q1 earnings.Alterity Therapeutics (NASDAQ:ATHE) -17%.Nikola (NASDAQ:NKLA) -15% on Q2 earnings.Sintx Technologies (NASDAQ:SINT) -14%.Corcept Therapeutics (NASDAQ:CORT) -11% on Q2 earnings.Invitae (NYSE:NVTA) -11% on Q2 earnings.Callon Petroleum (NYSE:CPE) -10% on Q2 earnings.Zhongchao (NASDAQ:ZCMD) -8%.Glu Mobile (NASDAQ:GLUU) -8% on Q2 earnings.Arcimoto (NASDAQ:FUV) -7%.Beyond Meat (NASDAQ:BYND) -7% on Q2 earnings.GenMark Diagnostics (NASDAQ:GNMK) -6% on Q2 earnings.Upwork (NASDAQ:UPWK) -7% on Q2 earnings.Sonnet BioTherapeutics (NASDAQ:SONN) -6%.Northern Dynasty Minerals (NYSEMKT:NAK) -5% after Trump Jr.
IMV (NASDAQ:IMV) +162% rallies on COVID-19 vaccine progress.VolitionRx (NYSEMKT:VNRX) +71% on encouraging COVID-19 test data.INmune Bio (NASDAQ:INMB) +65% as lead drug shows encouraging action in early-stage Alzheimer's study.My Size (NASDAQ:MYSZ) +47%.Boxlight (NASDAQ:BOXL) +18%.Rigel Pharmaceuticals (NASDAQ:RIGL) +16% on launching fostamatinib trial in patients with COVID-19 pneumonia.Celyad Oncology (NASDAQ:CYAD) +12% on advancement of CAR-T candidate CYAD-211.Arcimoto (NASDAQ:FUV) +11%.Houghton Mifflin Harcourt (NASDAQ:HMHC) +11%.T2 Biosystems (NASDAQ:TTOO) +9%.Vaxart (NASDAQ:VXRT) +9%.Dare Bioscience (NASDAQ:DARE) +9%.AgEagle Aerial Systems (NYSEMKT:UAVS) +9%.Future FinTech (NASDAQ:FTFT) +8%.electroCore (NASDAQ:ECOR) +7% on emergency use nod in U.S.
Navellier RatingsPowered by Portfolio Grader